Rhabdomyosarcoma of the urinary bladder in adults: Predilection for alveolar morphology with anaplasia and significant morphologic overlap with small cell carcinoma

American Journal of Surgical Pathology

Volumn 32, Issue 7, 2008, Pages 1022-1028

  Paner, Gladell P ^a   McKenney, Jesse K ^b   Epstein, Jonathan I ^c   Amin, Mahul B ^a  

^a Cedars Sinai Medical Center   (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^c JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

Adult; Alveolar; MyoD1; Myogenin; Rhabdomyosarcoma; Small cell carcinoma; Synaptophysin; Urinary bladder

Indexed keywords

CYCLOPHOSPHAMIDE; CYTARABINE; DESMIN; DOXORUBICIN; ETOPOSIDE; MITOXANTRONE; MYOD1 PROTEIN; MYOGENIN; SYNAPTOPHYSIN; VINCRISTINE; MYOD PROTEIN; MYOD1 MYOGENIC DIFFERENTIATION PROTEIN; TUMOR MARKER;

ADULT; AGED; ANAPLASTIC CARCINOMA; ARTICLE; BLADDER CANCER; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER MORTALITY; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CYSTECTOMY; CYTOPLASM; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; MALE; METASTASIS; RHABDOMYOSARCOMA; SMALL CELL CARCINOMA; SPINDLE CELL SARCOMA; UROGENITAL TRACT TUMOR; BLADDER TUMOR; CASE REPORT; CELL NUCLEUS; CHEMISTRY; DIFFERENTIAL DIAGNOSIS; FATALITY; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; PATHOLOGY;

ADULT; AGED; AGED, 80 AND OVER; ANAPLASIA; CARCINOMA, SMALL CELL; CELL NUCLEUS; COMBINED MODALITY THERAPY; DESMIN; DIAGNOSIS, DIFFERENTIAL; FATAL OUTCOME; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOD PROTEIN; MYOGENIN; RHABDOMYOSARCOMA, ALVEOLAR; SYNAPTOPHYSIN; TUMOR MARKERS, BIOLOGICAL; URINARY BLADDER NEOPLASMS;

EID: 47249139165     PISSN: 01475185     EISSN: 15320979     Source Type: Journal    
DOI: 10.1097/PAS.0b013e3181650e4a     Document Type: Article

References (35)

1. Ahlering TE, Weintraub P, Skinner DG. Management of adult sarcomas of the bladder and prostate. J Urol. 1988;140:1397-1399.
2. Amin MB, Ro JY, Lee KM, et al. Lymphoepithelioma-like carcinoma of the urinary bladder. Am J Surg Pathol. 1994;18: 466-473.
3. Aydoganli L, Tarhan F, Atan A, et al. Rhabdomyosarcoma of the urinary bladder in an adult. Int Urol Nephrol. 1993;25:159-161.
4. Beckwith JB, Palmer NF. Histopathology and prognosis of Wilms tumors: results from the First National Wilms' Tumor Study. Cancer. 1978;41:1937-1948.
5. Boue DR, Parham DM, Webber B, et al. Clinicopathologic study of ectomesenchymomas from Intergroup Rhabdomyosarcoma Study Groups III and IV. Pediatr Dev Pathol. 2000;3:290-300.
6. Cessna MH, Zhou H, Perkins SL, et al. Are myogenin and myoD1 expression specific for rhabdomyosarcoma? A study of 150 cases, with emphasis on spindle cell mimics. Am J Surg Pathol. 2001;25: 1150-1157.
7. Cheng L, Pan CX, Yang XJ, et al. Small cell carcinoma of the urinary bladder: a clinicopathologic analysis of 64 patients. Cancer. 2004;101:957-962.
8. Choong NW, Quevedo JF, Kaur JS. Small cell carcinoma of the urinary bladder. The Mayo Clinic experience. Cancer. 2005;103: 1172-1178.
9. Eusebi V, Damiani S, Pasquinelli G, et al. Small cell neuroendocrine carcinoma with skeletal muscle differentiation: report of three cases. Am J Surg Pathol. 2000;24:223-230.
10. Ferrer FA, Isakoff M, Koyle MA. Bladder/prostate rhabdomyo-sarcoma: past, present and future. J Urol. 2006;176:1283-1291.
11. Folpe AL. MyoD1 and myogenin expression in human neoplasia: a review and update. Adv Anat Pathol. 2002;9:198-203.
12. Gaffney EF, Dervan PA, Fletcher CD. Pleomorphic rhabdomyo-sarcoma in adulthood. Analysis of 11 cases with definition of diagnostic criteria. Am J Surg Pathol. 1993;17:601-609.
13. Grignon DJ, Ro JY, Ayala AG, et al. Small cell carcinoma of the urinary bladder. A clinicopathologic analysis of 22 cases. Cancer. 1992;69:527-536.
14. Hughes M, Morrison A, Jackson R. Primary bladder lymphoma: management and outcome of 12 patients with a review of the literature. Leuk Lymphoma. 2005;46:873-877.
15. Kerr KM, Grigor KM, Tolley DA. Rhabdomyosarcoma of the adult urinary bladder after radiotherapy for carcinoma. Clin Oncol (R Coll Radiol). 1989;1:115-116.
16. Kodet R, Newton WA Jr, Hamoudi AB, et al. Childhood rhabdomyosarcoma with anaplastic (pleomorphic) features. A report of the Intergroup Rhabdomyosarcoma Study. Am J Surg Pathol. 1993;17:443-453.
17. Kunze E, Theuring F, Kruger G. Primary mesenchymal tumors of the urinary bladder. A histological and immunohistochemical study of 30 cases. Pathol Res Pract. 1994;190:311-332.
18. Lambert I, Debiec-Rychter M, Dubin M, et al. Solid alveolar rhabdomyosarcoma originating from the urinary bladder in an adult. Diagnostic value of molecular genetics. Histopathology. 2004; 44:508-510.
19. Lauro S, Lalle M, Scucchi L, et al. Rhabdomyosarcoma of the urinary bladder in an elderly patient. Anticancer Res. 1995;15: 627-629.
20. Leroy X, Petit ML, Fayoux P, et al. Aberrant diffuse expression of synaptophysin in a sinonasal alveolar rhabdomyosarcoma. Pathology. 2007;39:275-276.
21. Leuschner I, Harms D, Mattke A, et al. Rhabdomyosarcoma of the urinary bladder and vagina: a clinicopathologic study with emphasis on recurrent disease: a report from the Kiel Pediatric Tumor Registry and the German CWS Study. Am J Surg Pathol. 2001;25: 856-864.
22. Lopez-Beltran A, Pacelli A, Rothenberg HJ, et al. Carcinosarcoma and sarcomatoid carcinoma of the bladder: clinicopathological study of 41 cases. J Urol. 1998;159:1497-1503.
23. Lopez-Beltran A, Perez-Seoane C, Montironi R, et al. Primary primitive neuroectodermal tumour of the urinary bladder: a clinico-pathological study emphasising immunohistochemical, ultrastruc-tural and molecular analyses. J Clin Pathol. 2006;59:775-778.
24. Meza JL, Anderson J, Pappo AS, et al. Analysis of prognostic factors in patients with nonmetastatic rhabdomyosarcoma treated on Intergroup Rhabdomyosarcoma Studies III and IV: the Children's Oncology Group. J Clin Oncol. 2006;24:3844-3851.
25. Mills SE, Wolfe JT III, Weiss MA, et al. Small cell undifferentiated carcinoma of the urinary bladder. A light-microscopic, immunocy-tochemical, and ultrastructural study of 12 cases. Am J Surg Pathol. 1987;11:606-617.
26. Morotti RA, Nicol KK, Parham DM, et al. An immunohistochem-ical algorithm to facilitate diagnosis and subtyping of rhabdomyo-sarcoma: the Children's Oncology Group experience. Am J Surg Pathol. 2006;30:962-968.
27. Newton WA Jr, Soule EH, Hamoudi AB, et al. Histopathology of childhood sarcomas, Intergroup Rhabdomyosarcoma Studies I and II: clinicopathologic correlation. J Clin Oncol. 1988;6:67-75.
28. Newton WA Jr, Gehan EA, Webber BL, et al. Classification of rhabdomyosarcomas and related sarcomas. Pathologic aspects and proposal for a new classification - an Intergroup Rhabdomyosarcoma Study. Cancer. 1995;76:1073-1085.
29. Nishio J, Althof PA, Bailey JM, et al. Use of a novel FISH assay on paraffin-embedded tissues as an adjunct to diagnosis of alveolar rhabdomyosarcoma. Lab Invest. 2006;86:547-556.
30. Pappo AS. Rhabdomyosarcoma and other soft tissue sarcomas in children. Curr Opin Oncol. 1996;8:311-316.
31. Perret L, Chaubert P, Hessler D, et al. Primary heterologous carcinosarcoma (metaplastic carcinoma) of the urinary bladder: a clinicopathologic, immunohistochemical, and ultrastructural analysis of eight cases and a review of the literature. Cancer. 1998;82: 1535-1549.
32. Sorensen PH, Lynch JC, Qualman SJ, et al. PAX3-FKHR and PAX7-FKHR gene fusions are prognostic indicators in alveolar rhabdomyosarcoma: a report from the children's oncology group. J Clin Oncol. 2002;20:2672-2679.
33. Taylor RE, Busuttil A. Case report: adult rhabdomyosarcoma of bladder, complete response to radiation therapy. J Urol. 1989;142: 1321-1322.
34. Zarabi CM, Huntrakoon M, Fine KD. Disseminated rhabdomyo-sarcoma of the urinary bladder in an adult. South Med J. 1987;80: 526-529.
35. Ziari M, Sonpavde G, Shen S, et al. Rhabdomyosarcoma of the urinary bladder in an adult. J Clin Oncol. 2005;23:4459-4460.